CDC Website CDC Website

To Join the NPIN community or

Home » Mood Disorders in People Living with HIV: Mechanisms and Pathways (R21 Clinical Trial Optional)

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Mood Disorders in People Living with HIV: Mechanisms and Pathways (R21 Clinical Trial Optional)

The purpose of this initiative is to support studies to better understand the underlying mechanisms and interplay of biological, psychosocial and structural factors contributing to mood disorders in people living with HIV. Exploratory and high-risk research projects are appro?priate for this funding opportunity announcement. Applications testing a fully conceptualized and hypothesis-based solid premise founded with adequate preliminary data should consider applying to the companion R01 announcement RFA-MH-21-116. Basic and preclinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Letter of Intent Date
2/10/21
Application Due Date
3/10/21
Project Start Date
9/1/21
Application Contact
Rita
Sisco
Team Leader, Grants Management Branch
301-443-2805
siscor@mail.nih.gov
Technical Contact
Vasudev
R
Rao, MBBS, MS
Scientific/Research Contact
vasudev.rao@nih.gov
301-825-3259
Fund Duration
The maximum project period is 2 years.
Subjects
Audiences

Fund Number: 

352139

Fund ID: 

RFA-MH-21-117

Last modified: 

12/14/20